SFRP2 and malignant colon neoplasm: Zhang et al. revealed that treating colon cancer cells (DLD-1) with 75 μM/L of genistein resulted in a reduction of promoter methylation of the SFRP2 gene by up to 50%, a result comparable to that of 5-aza-cytidine, a DNA methyltransferase inhibitor.